Clearmind Medicine CMND
NASDAQ CMND
$0.73 +0.02 (+2.60%)
As of: Oct 2, 2026 · 2:29 PM EDT

Clearmind Medicine (CMND) Selling, General & Administrative (2022 - 2026)

Updated

Clearmind Medicine (CMND) reported Selling, General & Administrative of $1.59 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 132.3% from $684,716 a year earlier and up 72.1% from the prior quarter.

Analysis

Clearmind Medicine (CMND) Selling, General & Administrative (2022 - 2026) Analysis & Trends

Over the twelve months ended Jul 31, 2026, Clearmind Medicine's Selling, General & Administrative came in at $6.57 million, up 78.8% year-over-year; for FY2025 (ended Oct 31, 2025), it was $3.61 million, down 17.2% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 83.5% (FY2020 to FY2025).
  • By fiscal year, Selling, General & Administrative came in at $4.36 million in FY2024 (-8.3%), $4.76 million in FY2023 (+50.1%), $3.17 million in FY2022 (+42.8%) and $2.22 million in FY2021.
  • Five-year quarterly Selling, General & Administrative spans a low of -$131,315 in fiscal Q4 2022 and a high of $3.02 million in fiscal Q1 2026.
  • Year over year, Selling, General & Administrative has now increased in each of the last three quarters, with growth averaging 30.8% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was fiscal Q1 2026 (growth of 191.8%); the low point was fiscal Q3 2025 (a decline of 39.2%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $924,502 (Q2 2026), $3.02 million (Q1 2026) and $1.04 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Clearmind Medicine 10,294.29 10,294.29 - 1.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 1.59 Mn
Apr 30, 2026 924,502.00
Jan 31, 2026 3.02 Mn
Oct 31, 2025 1.04 Mn
Jul 31, 2025 684,716.00
Apr 30, 2025 855,124.00
Jan 31, 2025 1.03 Mn
Oct 31, 2024 1.10 Mn
Jul 31, 2024 1.13 Mn
Apr 30, 2024 980,549.00
Jan 31, 2024 1.16 Mn
Oct 31, 2023 1.34 Mn
Jul 31, 2023 838,925.00
Apr 30, 2023 989,176.68
Jan 31, 2023 1.25 Mn
Oct 31, 2022 -131,315.00
Jul 31, 2022 1.03 Mn
Jan 31, 2022 1.31 Mn
API Access

Clearmind Medicine Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CMND&period=max&api_key=YOUR_API_KEY